Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service

AstraZeneca picks up rare disease-focused Amolyt Pharma in $1 billion deal

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease

March 14, 2024

Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t tracked

Before the Covid-19 pandemic, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined, including HIV, pneumonia, and

April 17, 2024

Medicare drug price negotiation didn’t benefit Biden — but it may help Harris

WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention next week, she’ll have a fresh policy achievement to tout:

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.